NYSEAMERICAN:CRHM - CRH Medical Stock Price, Forecast & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CRH Medical.

CRH Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for CRH Medical.

CRH Medical Corp (NYSEAMERICAN:CRHM) posted its earnings results on Wednesday, August, 1st. The company reported $0.02 EPS for the quarter, beating the Zacks' consensus estimate of $0.01 by $0.01. The company earned $27.33 million during the quarter, compared to analysts' expectations of $25.70 million. View CRH Medical's earnings history.

3 equities research analysts have issued 12-month price objectives for CRH Medical's shares. Their forecasts range from $4.00 to $4.75. On average, they expect CRH Medical's stock price to reach $4.38 in the next year. This suggests a possible upside of 252.8% from the stock's current price. View analysts' price targets for CRH Medical.

Media headlines about CRHM stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. CRH Medical earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutCRH Medical.

CRH Medical saw a drop in short interest during the month of March. As of March 13th, there was short interest totaling 11,600 shares, a drop of 38.6% from the February 27th total of 18,900 shares. Based on an average daily volume of 61,300 shares, the short-interest ratio is presently 0.2 days. Currently, 0.0% of the shares of the company are short sold. View CRH Medical's Current Options Chain.

Some companies that are related to CRH Medical include Enerplus (ERF), Clover (CLV), Bovie Medical (BVX), Tristel (TSTL), CRH Medical (CRH), InfuSystem (INFU), Milestone Scientific (MLSS), SDI (SDI), Daxor (DXR), Daxor (DXR), Impression Healthcare (IHL), TSO3 (TOS), IsoRay (ISR), IsoRay (ISR) and Retractable Technologies (RVP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include CRH Medical (CRH), AcelRx Pharmaceuticals (ACRX), Extreme Networks (EXTR), Pieris Pharmaceuticals (PIRS), NovaBay Pharmaceuticals (NBY), Palatin Technologies (PTN), Alimentation Couche-Tard (ATD.B), Dollarama (DOL), Abeona Therapeutics (ABEO) and Anavex Life Sciences (AVXL).

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

CRH Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Stadium Capital Management LLC (6.80%), Beutel Goodman & Co Ltd. (6.10%), Pacific Ridge Capital Partners LLC (3.55%), Stifel Financial Corp (3.07%), Connor Clark & Lunn Investment Management Ltd. (3.00%) and Connor Clark & Lunn Investment Management Ltd. (3.00%). View institutional ownership trends for CRH Medical.

CRHM stock was sold by a variety of institutional investors in the last quarter, including Beutel Goodman & Co Ltd., Stadium Capital Management LLC, Seizert Capital Partners LLC, Stifel Financial Corp, and Wedge Capital Management L L P NC. View insider buying and selling activity for CRH Medical.

CRHM stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Palladium Partners LLC, Pacific Ridge Capital Partners LLC, Acadian Asset Management LLC, Cumberland Partners Ltd, Goldman Sachs Group Inc., Connor Clark & Lunn Investment Management Ltd., and Connor Clark & Lunn Investment Management Ltd.. View insider buying and selling activity for CRH Medical.

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CRHM stock can currently be purchased for approximately $1.24.

CRH Medical has a market capitalization of $88.80 million. CRH Medical employs 112 workers across the globe. View additional information about CRH Medical.

The official website for CRH Medical is http://investors.crhsystem.com/.

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.